192 related articles for article (PubMed ID: 30327187)
21. [Familial medullary thyroid carcinoma: case report and literature review.].
Barletta Carrillo CF; Poterico Rojas JA; Barrionuevo Cornejo C; Casavilca Zambrano S; Pinedo Cárdenas A; Quispe Santibañez I; Castro Mujica MDC
Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):303-309. PubMed ID: 30734711
[TBL] [Abstract][Full Text] [Related]
22. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
Jung KY; Kim SM; Kim MJ; Cho SW; Kim BW; Lee YS; Jeong JJ; Nam KH; Chung WY; Lee KE; Chung EJ; Kim HJ; Park DJ; Sung MW; Park CS; Cho BY; Park YJ; Chang HS
Surgery; 2018 Aug; 164(2):312-318. PubMed ID: 29779869
[TBL] [Abstract][Full Text] [Related]
23. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
24. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
[TBL] [Abstract][Full Text] [Related]
25. Familial non-multiple endocrine neoplasia medullary thyroid carcinoma: report of a case confirming a new clinical entity in Japan.
Katagiri M; Ohtawa T; Ito K; Harada T
Surg Today; 1995; 25(9):822-6. PubMed ID: 8555702
[TBL] [Abstract][Full Text] [Related]
26. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
[TBL] [Abstract][Full Text] [Related]
27. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems.
Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH
Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905
[TBL] [Abstract][Full Text] [Related]
28. Prospective screening in familial nonmedullary thyroid cancer.
Sadowski SM; He M; Gesuwan K; Gulati N; Celi F; Merino MJ; Nilubol N; Kebebew E
Surgery; 2013 Dec; 154(6):1194-8. PubMed ID: 23978593
[TBL] [Abstract][Full Text] [Related]
29. Role of Age at Diagnosis in Defining Potential Familial Nonmedullary Thyroid Cancer in Kindreds With Two Affected Members.
Capezzone M; Sagnella A; Pilli T; Maino F; Forleo R; Cantara S; Cartocci A; Castagna MG
J Clin Endocrinol Metab; 2021 Jan; 106(2):e855-e865. PubMed ID: 33175120
[TBL] [Abstract][Full Text] [Related]
30. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study.
Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D
Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559
[TBL] [Abstract][Full Text] [Related]
31. Familial thyroid carcinoma: a diagnostic algorithm.
Dotto J; Nosé V
Adv Anat Pathol; 2008 Nov; 15(6):332-49. PubMed ID: 18948764
[TBL] [Abstract][Full Text] [Related]
32. Disseminated medullary thyroid cancer after early thyroid surgery in multiple endocrine neoplasia type 2A.
de Groot JW; Links T; Plukker J
Thyroid; 2005 Oct; 15(10):1205-6; author reply 1206-7. PubMed ID: 16425443
[No Abstract] [Full Text] [Related]
33. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
[TBL] [Abstract][Full Text] [Related]
34. Surgical management and follow-up of medullary thyroid carcinoma.
Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
[TBL] [Abstract][Full Text] [Related]
35. Familial nonmedullary thyroid carcinoma: a meta-review of case series.
Loh KC
Thyroid; 1997 Feb; 7(1):107-13. PubMed ID: 9086578
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and prognosis of familial nonmedullary thyroid carcinoma.
de Carlos Artajo J; Irigaray Echarri A; García Torres J; Pineda Arribas JJ; Ernaga Lorea A; Eguílaz Esparza N; Zubiría Gortázar JM; Anda Apiñániz E
Endocrinol Diabetes Nutr (Engl Ed); 2022 Apr; 69(4):262-270. PubMed ID: 35353680
[TBL] [Abstract][Full Text] [Related]
37. Biological behavior and prognosis of familial papillary thyroid carcinoma.
Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
[TBL] [Abstract][Full Text] [Related]
38. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
39. Right posterior paratracheal lymph nodes metastasis is one of the predictive factors in right-sided papillary thyroid carcinoma.
Kim D; Kwon HK; Shin SC; Sung ES; Jeon YK; Kim BH; Kim IJ; Lee JC; Lee BJ
Surgery; 2019 Dec; 166(6):1154-1159. PubMed ID: 31444006
[TBL] [Abstract][Full Text] [Related]
40. Analysis of risk factors for postoperative recurrence of thyroid cancer.
Luo X; Wu ACYZYJBZJ
J BUON; 2019; 24(2):813-818. PubMed ID: 31128040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
